KIMBERLY WHITLOCK: Open Payments
NPI 1467142463 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,490 in 125 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $2,490
Food & beverage: $2,490
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $237 |
| UCB, Inc. | 10 | $211 |
| Amneal Pharmaceuticals LLC | 16 | $189 |
| Neurocrine BioSciences, Inc. | 4 | $178 |
| Teva Pharmaceuticals USA, Inc. | 7 | $172 |
| Lundbeck LLC | 11 | $170 |
| Grifols USA, LLC | 7 | $153 |
| Mallinckrodt Hospital Products Inc. | 6 | $138 |
| Medtronic, Inc. | 1 | $114 |
| Genentech USA, Inc. | 5 | $93 |
Products named: REXULTI, CREXONT, INGREZZA, Gamunex-C, QULIPTA, ACTHAR, Nayzilam, SENSIGHT.
Industry payments across AZ — which companies pay providers there.
